Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
HUTCHMED (NASDAQ:HCM) announced Wednesday the initiation of a Phase I/IIa clinical trial for HMPL-A580, marking the first human testing of its second antibody-targeted therapy conjugate (ATTC) for the treatment of solid tumors.
Crypto exchange Bybit said it recovered $300 million for thousands of users in 2025 using an artificial intelligence-powered fraud detection system designed to intercept scams before funds are lost.
A Los Angeles County jury has convicted former Los Angeles Police Department officer Eric Halem of kidnapping and robbery after prosecutors said he and three alleged accomplices posed as police to steal roughly $350,000 in Bitcoin from a 17-year-old during a 2024 home invasion.
Binance has launched seven AI Agent Skills that allow automated systems to access spot trading, wallet data and advanced order types through a unified interface.
More than $10 million in crypto flowed out of Iranian exchanges after US and Israeli strikes, according to blockchain analytics firms, highlighting heightened capital movement amid escalating geopolitical tension.
GenusPlus Group (ASX:GNP) has entered into a binding agreement to acquire 100% of Railtrain, a move designed to bolster its presence in the national rail infrastructure sector.
Neuren Pharmaceuticals' (ASX:NEU) North American partner, Acadia Pharmaceuticals (NASDAQ:ACAD), will request a re-examination of its marketing application for trofinetide in Europe.
Core Scientific (NASDAQ:CORZ) signaled a definitive departure from its identity as a pure-play cryptocurrency miner on Monday, announcing plans to sell nearly all of its remaining Bitcoin to finance a capital-intensive transition into artificial intelligence and high-performance computing (HPC).
Aurelion (NASDAQ:AURE) reported unaudited first-quarter 2026 results on Tuesday, unveiling a balance sheet now almost entirely defined by its new mandate as the first Nasdaq-listed treasury focused on Tether Gold (XAUt).
Prime Medicine (NASDAQ:PRME) reported full-year 2025 financial results on Tuesday, signaling a strategic shift toward commercial-stage readiness as its "search-and-replace" gene editing platform achieves its first human clinical validations.
